Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1970 Apr;1(4):334–337. doi: 10.1128/iai.1.4.334-337.1970

Preparation of Cholera Vaccines by Fluorocarbon Extraction of Cholera Vibrio Suspensions

Patricia L Altieri 1, Sanford Berman 1, Albert Groffinger 1, Joseph P Lowenthal 1
PMCID: PMC415902  PMID: 16557738

Abstract

Experimental cholera vaccines were prepared from suspensions of cholera vibrios which were extracted with Genetron-113. These vaccines, when compared with a control preparation which was not treated with Genetron, had a lower nitrogen content and were less toxic for mice but were as effective in protecting mice against infection and in inducing agglutinating and vibriocidal antibody responses in rabbits. This procedure may permit the preparation of cholera vaccines with a higher antigenic content without the corresponding increase in toxic reactions.

Full text

PDF
334

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Das Gupta A., Sinha R., Shrivastava D. L., De S. P., Taneja B. L., Rao M. S., Abou-Gareeb A. H. Controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in Calcutta. Bull World Health Organ. 1967;37(3):371–385. [PMC free article] [PubMed] [Google Scholar]
  2. FEELEY J. C., PITTMAN M. LABORATORY ASSAYS OF CHOLERA VACCINE USED IN FIELD TRIAL IN EAST PAKISTAN, 1963. Lancet. 1965 Feb 27;1(7383):449–450. doi: 10.1016/s0140-6736(65)91585-0. [DOI] [PubMed] [Google Scholar]
  3. HAMPARIAN V. V., MULLER F., HUMMELER K. Elimination of nonspecific components from viral antigens by fluorocarbon. J Immunol. 1958 Jun;80(6):468–475. [PubMed] [Google Scholar]
  4. MARKOWITZ A. S., HENDERSON J. R. A rapid specific method for the isolation of pneumococcal polysaccharide. Nature. 1958 Mar 15;181(4611):771–772. doi: 10.1038/181771b0. [DOI] [PubMed] [Google Scholar]
  5. OSEASOHN R. O., BENENSON A. S., FAHIMUDDIN M. FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION. Lancet. 1965 Feb 27;1(7383):450–452. doi: 10.1016/s0140-6736(65)91586-2. [DOI] [PubMed] [Google Scholar]
  6. PITTMAN M., FEELEY J. C. Protective activity of cholera vaccines against E1 Tor cholera vibrios. Bull World Health Organ. 1963;28(3):379–383. [PMC free article] [PubMed] [Google Scholar]
  7. Worcester J., Wilson E. B. A Table Determining L.D.50 or the Fifty Per Cent End-Point. Proc Natl Acad Sci U S A. 1943 Jul;29(7):207–212. doi: 10.1073/pnas.29.7.207. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES